These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7810170

  • 1. Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats.
    Urban G, Dekant W.
    Xenobiotica; 1994 Sep; 24(9):881-92. PubMed ID: 7810170
    [Abstract] [Full Text] [Related]

  • 2. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
    Dekant W, Assmann M, Urban G.
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
    [Abstract] [Full Text] [Related]

  • 3. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation.
    Harris JW, Jones JP, Martin JL, LaRosa AC, Olson MJ, Pohl LR, Anders MW.
    Chem Res Toxicol; 1992 Dec; 5(5):720-5. PubMed ID: 1446014
    [Abstract] [Full Text] [Related]

  • 4. Biotransformation and hepatotoxicity of HCFC-123 in the guinea pig: potentiation of hepatic injury by prior glutathione depletion.
    Lind RC, Gandolfi AJ, Hall PD.
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):175-81. PubMed ID: 7676453
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of 1,2-dichloro-1-fluoroethane and 1-fluoro-1,2,2-trichloroethane: electronic factors govern the regioselectivity of cytochrome P450-dependent oxidation.
    Yin H, Anders MW, Jones JP.
    Chem Res Toxicol; 1996 Sep; 9(1):50-7. PubMed ID: 8924616
    [Abstract] [Full Text] [Related]

  • 6. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R, Tolando R, King LJ, Manno M.
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [Abstract] [Full Text] [Related]

  • 7. Investigations on the liver toxicity of a blend of HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane) and HCFC-124 (2-chloro-1,1,1,2-tetrafluoroethane) in guinea-pigs.
    Hoet P, Buchet JP, Sempoux C, Nomiyama T, Rahier J, Lison D.
    Arch Toxicol; 2001 Jul; 75(5):274-83. PubMed ID: 11548120
    [Abstract] [Full Text] [Related]

  • 8. Metabolism of 1-fluoro-1,1,2-trichloroethane, 1,2-dichloro-1,1-difluoroethane, and 1,1,1-trifluoro-2-chloroethane.
    Yin H, Jones JP, Anders MW.
    Chem Res Toxicol; 1995 Mar; 8(2):262-8. PubMed ID: 7766810
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)-induced liver toxicity by ethanol in guinea-pigs.
    Hoet P, Buchet JP, Sempoux C, Haufroid V, Rahier J, Lison D.
    Arch Toxicol; 2002 Dec; 76(12):707-14. PubMed ID: 12451447
    [Abstract] [Full Text] [Related]

  • 10. Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
    Loizou GD, Urban G, Dekant W, Anders MW.
    Drug Metab Dispos; 1994 Dec; 22(4):511-7. PubMed ID: 7956723
    [Abstract] [Full Text] [Related]

  • 11. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
    Schuster P, Bertermann R, Snow TA, Han X, Rusch GM, Jepson GW, Dekant W.
    Toxicol Appl Pharmacol; 2008 Dec 01; 233(2):323-32. PubMed ID: 18817801
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of 1,1-dichloro-1-fluoroethane (HCFC-141b) in human volunteers.
    Tong Z, Utell MJ, Morrow PE, Rusch GM, Anders MW.
    Drug Metab Dispos; 1998 Jul 01; 26(7):711-3. PubMed ID: 9660855
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.
    Urban G, Speerschneider P, Dekant W.
    Chem Res Toxicol; 1994 Jul 01; 7(2):170-6. PubMed ID: 8199305
    [Abstract] [Full Text] [Related]

  • 14. Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: a physiologically based pharmacokinetic model in the male Fischer 344 rat.
    Vinegar A, Williams RJ, Fisher JW, McDougal JN.
    Toxicol Appl Pharmacol; 1994 Nov 01; 129(1):103-13. PubMed ID: 7974482
    [Abstract] [Full Text] [Related]

  • 15. Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
    Loizou GD, Anders MW.
    Drug Metab Dispos; 1993 Nov 01; 21(4):634-9. PubMed ID: 8104122
    [Abstract] [Full Text] [Related]

  • 16. Biotransformation of trans-1,1,1,3-tetrafluoropropene (HFO-1234ze).
    Schuster P, Bertermann R, Rusch GM, Dekant W.
    Toxicol Appl Pharmacol; 2009 Sep 15; 239(3):215-23. PubMed ID: 19573548
    [Abstract] [Full Text] [Related]

  • 17. Toxicology of chlorofluorocarbon replacements.
    Dekant W.
    Environ Health Perspect; 1996 Mar 15; 104 Suppl 1(Suppl 1):75-83. PubMed ID: 8722112
    [Abstract] [Full Text] [Related]

  • 18. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane.
    Huwyler J, Aeschlimann D, Christen U, Gut J.
    Eur J Biochem; 1992 Jul 01; 207(1):229-38. PubMed ID: 1628651
    [Abstract] [Full Text] [Related]

  • 19. Metabolism and pharmacokinetics of selected halon replacement candidates.
    Dodd DE, Brashear WT, Vinegar A.
    Toxicol Lett; 1993 May 01; 68(1-2):37-47. PubMed ID: 8516773
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of 14C-dichloroethyne in rats.
    Kanhai W, Koob M, Dekant W, Henschler D.
    Xenobiotica; 1991 Jul 01; 21(7):905-16. PubMed ID: 1776266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.